1.
Psychiatry Res
; 229(1-2): 586-8, 2015 Sep 30.
Article
in English
| MEDLINE
| ID: mdl-26213377
ABSTRACT
Previous association results between dopamine D1 receptor (DRD1) rs4532 polymorphism and antipsychotic treatment response in schizophrenia and schizoaffective subjects have been conflicting. Thus, we have conducted a systematic review followed by a meta-analysis. Our results indicated no association between DRD1 rs4532 polymorphism and overall antipsychotic response or clozapine monotherapy response.